stella
beta
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. — Stella
Recruiting
Back to Resectable Esophageal Squamous Cell Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(5 sites)
China
Shanghai Chest Hospital, Shanghai, Shanghai Municipality
Anyang Tumour Hospital, Anyang
Sun yat-sen University Cancer Center, Guangzhou
Anhui Provincial Hospital, Hefei
Zhongshan Hospital of Fudan University, Shanghai
View full record on ClinicalTrials.gov